Asthma, allergy and the olympics: A 12-year survey in elite athletes

Current Opinion in Allergy and Clinical Immunology

Volumn 15, Issue 2, 2015, Pages 184-192

  Bonini, Matteo ^a,b   Gramiccioni, Claudia ^b,c   Fioretti, Daniela ^c   Ruckert, Beate ^d   Rinaldi, Monica ^c   Akdis, Cezmi ^d   Todaro, Antonio ^e   Palange, Paolo ^a   Carlsen, Kai Hakon ^f   Pelliccia, Antonio ^e   Rasi, Guido ^g   Bonini, Sergio ^c,h   AIDA, ⁱ  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^c Italian Drug Agency (AIFA)   (Italy)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e Institute of Sports Medicine and Science   (Italy)

^f NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

^g EUROPEAN MEDICINES AGENCY   (United Kingdom)

^h SECOND UNIVERSITY OF NAPLES   (Italy)

ⁱ NONE

Author keywords

allergy; asthma; athlete; exercise; infection

Indexed keywords

AUTOANTIBODY; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; IFNG PROTEIN, HUMAN; IL4 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ALLERGY; ANAPHYLAXIS; ARTICLE; ASTHMA; ATHLETE; AUTOIMMUNE DISEASE; BRONCHOCONSTRICTION; CLINICAL FEATURE; CONJUNCTIVITIS; CROSS-SECTIONAL STUDY; DOWN REGULATION; EXERCISE; EXERCISE INDUCED BRONCHOCONSTRICTION; FEMALE; FLOW CYTOMETRY; HEALTH CARE SURVEY; HERPES SIMPLEX; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PRIORITY JOURNAL; RHINITIS; SKIN ALLERGY; SKIN TEST; T LYMPHOCYTE SUBPOPULATION; TREND STUDY; AUTOIMMUNE DISEASES; BLOOD; CLINICAL TRIAL; FOLLOW UP; IMMUNOLOGY; METABOLISM; PREVALENCE; SPORT; TH2 CELL;

ADOLESCENT; ADULT; ASTHMA; ATHLETES; AUTOIMMUNE DISEASES; FEMALE; FOLLOW-UP STUDIES; HERPES SIMPLEX; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-4; MALE; PREVALENCE; SPORTS; TH2 CELLS;

EID: 84923876825     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000149     Document Type: Article

References (39)

1. Helenius IJ, Haahtela T. Allergy and asthma in elite summer sport athletes. J Allergy Clin Immunol 2000; 106:444-452.
2. Larsson K, Ohlsen P, Larsson L, et al. High prevalence of asthma in cross country skiers. BMJ 1993; 307:1326-1329.
3. Carlsen KH, Anderson SA, Bjermer L, et al. Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN. Allergy 2008; 63:387-403.
4. Fitch KD. Management of allergic Olympic athletes. J Allergy Clin Immunol 1984; 73:722-727.
5. Katelaris CH, Carozzi FM, Burke TV, et al. A springtime Olympics demands special consideration for allergic athletes. J Allergy Clin Immunol 2000; 106:260-266.
6. Voy RO, The US. Olympic Committee experience with exercise-induced bronchospasm, 1984. Med Sci Sports Exerc 1986; 18:328-330.
7. Weiler JM, Layton T, Hunt M. Asthma in United States Olympic athletes who participated in the 1996 Summer Games. J Allergy Clin Immunol 1998; 102:722-726.
8. Moreira A, Delgado L, Carlsen K-H. Exercise-induced asthma: why is it so frequent in Olympic athletes. Expert Rev Respir Med 2011; 5:1-3.
9. Fitch KD. An overview of asthma and airway hyper-responsiveness in Olympic athletes. Br J Sports Med 2012; 46:413-416.
10. Weiler JM, Anderson SD, Bonini S, et al. Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter. Ann Asthma Allergy Immunol 2010; 105:S1-S47.
11. Helenius IJ, Rytilä P, Sarna S, et al. Effect of continuing or finishing high-level sports on airway inflammation, bronchial hyperresponsiveness, and asthma: a 5-year prospective follow-up study of 42 highly trained swimmers. J Allergy Clin Immunol 2002; 109:962-968.
12. Anderson SD, Kippelen P. Airway injury as a mechanism for exercise-induced bronchoconstriction in elite athletes. J Allergy Clin Immunol 2008; 122:223-235.
13. Becker JM, Rogers J, Rossini G, et al. Asthma deaths during sports: report of a 7-year experience. J Allergy Clin Immunol 2004; 113:264-267.
14. Moreira A, Delgado L, Moreira P, et al. Does exercise increase the risk of upper respiratory tract infections? Br med Bull 2009; 90:111-131.
15. Walsh NP, Gleeson M, Shephard RJ, et al. Position Statement. Part One: immune function and exercise. Exerc Immunol Rev 2011; 17:6-63.
16. Fields KB, Thekkekandam TJ, Neal S. Wheezing after URTI in athletes. Curr Sports Med Rep 2012; 11:85-89.
17. Helenius IJ, Tikkanen I, Sarna S, et al. Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors. J Allergy Clin Immunol 1998; 101:646-652.
18. Helbling A, Jenoure P, Muller U. The incidence of hay fever in leading Swiss athletes. Schweiz Med Wochenschr 1990; 120:231-236.
19. Schwartz LB, Delgado L, Craig T, et al. Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy). Allergy 2008; 63:953-961.
20. Passali D, Damiani GC, Passali FM, et al. Alterations in rhinosinusal homeostasis in a sportive population: our experience with 106 athletes. Eur Arch Otorhinolaryngol 2004; 261:502-506.
21. Katelaris CH, Carozzi FM, Burke TV, et al. Effects of intranasal budesonide on symptoms, quality of life, and performance in elite athletes with allergic rhinoconjunctivitis. Clin J Sport Med 2002; 12:296-300.
22. Bonini S, Bonini M, Bousquet J, et al. Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy 2006; 61:681-692.
23. Kockentiet B, Adams BB. Contact dermatitis in athletes. J Am Acad Dermatol 2007; 56:1048-1055.
24. Robson-Ansley P, Toidt DG. Pathophysiology, diagnosis and management of exercise-induced anaphylaxis. Curr Opinion Allergy Clin Immunol 2010; 10:312-317.
25. Belli S, Vanacore N. Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease? Eur J Epidemiol 2005; 20:237-242.
26. Gleeson M. Immune function in sport and exercise. J Appl Physiol 2007; 103:693-699.
27. Bonini M, Braido F, Baiardini I, et al. AQUA: Allergy Questionnaire for Athletes. Development and validation. Med Sci Sports Exerc 2009; 41:1034-1041.
28. Bonini S, Casasco M, editors. Allergy protocols for the judgment of fitness to practice sport. Med Sport 2009; 62 (Suppl 3).
29. de Marco R, Cappa V, Accordini S, et al. Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J 2012; 39:883-892.
30. Bonini M, Bachert C, Baena-Cagnani CE, et al. What we should learn from the London Olympics. Curr Opin Allergy Clin Immunol 2013; 13:1-3.
31. Steensberg A, Toft Dhyr A, Bruunsgaard H, et al. Strenuous exercise decreases the percentage of type 1 T cells in the circulation. J Appl Physiol 2001; 91:1708-1712.
32. Smith LL. Overtraining, excessive exercise, and altered immunity. Is this a Thelper1 versus T-helper2 lymphocytes response? Sports Med 2003; 33:347-364.
33. Bonini M, Fioretti D, Sargentini V, et al. Increased nerve growth factor serum levels in top athletes. Clin J Sport Med 2013; 23:228-231.
34. Lee IM, Shiroma EJ, Lobelo F, Puska P, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet Physical Activity Series Working Group. Lancet 2012; 380:219-229.
35. BoniniM, LapucciG, Petrelli G, et al. Predictive value of allergy and pulmonary function tests for the diagnosis of asthma in elite athletes. Allergy 2007; 62:1166-1170.
36. Melioli G, Bonifazi F, Bonini S, et al. The ImmunoCAP ISAC molecular allergology approach in multi-sensitized Italian patients with respiratory symptoms. Clin Biochem 2011; 44:1005-1011.
37. Chowdhury BA, Dal Pan G. The FDA and safe use of long-acting beta-agonists in the treatment of asthma. N Engl J Med 2010; 362:1169-1171.
38. Bonini M, Permaul P, Kulkarni T, et al. Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide. Am J Respir Crit Care Med 2013; 188:1407-1412.
39. Bonini M, Di Mambro C, Calderon MA, et al. Beta2-agonists for exercise-induced asthma. Cochrane Database Syst Rev 2013; 10:CD003564.